Tadeusz Robak MD, Ph.D. is Professor of Hematology at the Medical university of Lodz, Poland. Professor Robak studied medicine at this institution and after graduating in 1973 went on to specialize in internal medicine, clinical pharmacology and hematology at the Copernicus Memorial Hospital in Lodz. He undertook further postgraduate training at Hammersmith Hospital, London, in 1983-1984. He currently holds the posts of Professor of Hematology at the Medical University of Lodz and Chief of Department of Hematology at the Copernicus Memorial Hospital in Lodz. Professor Robak is a reviewer for numerous journals including Journal of Clinical Oncology, Blood, Lancet, Lancet Oncology, Leukemia, Leukaemia and Lymphoma, Drugs, Drugs and Aging, BioDrugs, European Journal of Haematology, and other journals. He is current president of the Polish Society of Hematology and a member of European Hematology Association and American Society for Hematology.The particular research emphasis has been on the application of new drugs in the treatment of leukemia multiple myeloma and lymphoma and interactions of antineoplastic agents.

Dr. Tadeusz Robak's research interests include: Chronic lymphocytic leukemia Acute myeloid leukemia Preclinical and clincal studies of nucleoside analogs and monoclonal antibodies in leukemia and lymphoma.